Novo's Wegovy Pill Delivers Further Weight Loss for Injection Switchers
Novo says patients switching from Wegovy or Zepbound injections to its new pill lost another 8.8 pounds on average in three months, per real-world telehealth data.
Topic
Obesity Drugs
Topic
Obesity Drugs
Eli Lilly Says One-Third of New GLP-1 Pill Patients Choose Foundayo
One-third of new GLP-1 pill patients pick Foundayo, CEO Dave Ricks says, as Lilly breaks ground on a $6.5 billion Houston plant d…